Ubs Group Ag Amphastar Pharmaceuticals, Inc. Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 122,681 shares of AMPH stock, worth $5.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122,681
Previous 80,452
52.49%
Holding current value
$5.89 Million
Previous $3.53 Million
38.93%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$285 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$128 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$93.4 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$81.2 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$77.9 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.35B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...